Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$17.85 USD

17.85
945,562

-0.49 (-2.67%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $17.84 -0.01 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 246)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Analysts Estimate AMN Healthcare Services (AMN) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Will AMN Healthcare (AMN) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

AMN Stock Gains Post Latest Deals With symplr to Boost Operations

by Zacks Equity Research

AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.

Zacks Equity Research

What Makes AMN Healthcare (AMN) a New Buy Stock

by Zacks Equity Research

AMN Healthcare (AMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Does AMN Healthcare (AMN) Have the Potential to Rally 29.32% as Wall Street Analysts Expect?

by Zacks Equity Research

The consensus price target hints at a 29.3% upside potential for AMN Healthcare (AMN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

Should Value Investors Buy AMN Healthcare Services (AMN) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

AMN Stock Gains Following Q1 Earnings & Revenue Beat, Margins Down

by Zacks Equity Research

AMN Healthcare's dismal results in all its segments led to a soft overall first-quarter 2025 performance.

Zacks Equity Research

AMN Healthcare (AMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for AMN Healthcare (AMN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

AMN Healthcare Services (AMN) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

AMN Healthcare (AMN) delivered earnings and revenue surprises of 136.84% and 2.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cencora (COR) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Cencora (COR) delivered earnings and revenue surprises of 8.33% and 0.85%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will AMN Healthcare (AMN) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Tracey Ryniec headshot

Value Investors: Are Stocks Cheap or Not?

by Tracey Ryniec

Tracey Ryniec, Zacks Value Stock Strategist, discusses stocks that may be cheap, or not, depending on where the economy goes. How can you tell?

Zacks Equity Research

Is the Options Market Predicting a Spike in AMN Healthcare (AMN) Stock?

by Zacks Equity Research

Investors need to pay close attention to AMN Healthcare (AMN) stock based on the movements in the options market lately.

Zacks Equity Research

New Strong Sell Stocks for February 25th

by Zacks Equity Research

AMN, CABGY and BNPQY have been added to the Zacks Rank #5 (Strong Sell) List on February 25, 2025.

Zacks Equity Research

AMN Stock Gains Following Q4 Earnings & Revenues Beat, Margins Down

by Zacks Equity Research

AMN Healthcare's dismal results in the majority of its segments led to a soft overall fourth-quarter performance.

Zacks Equity Research

Compared to Estimates, AMN Healthcare (AMN) Q4 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

AMN Healthcare Services (AMN) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

AMN Healthcare (AMN) delivered earnings and revenue surprises of 44.23% and 5.70%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Icon PLC (ICLR) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.29% and 0.29%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Indrajit Bandyopadhyay headshot

What to Expect From These 3 MedTech Stocks This Earnings Season?

by Indrajit Bandyopadhyay

Here is a sneak peek into how three MedTech stocks, GKOS, ITGR and AMN, are expected to fare in their quarterly results, slated to be released tomorrow.

Zacks Equity Research

Insights Into AMN Healthcare (AMN) Q4: Wall Street Projections for Key Metrics

by Zacks Equity Research

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for AMN Healthcare (AMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.

Tracey Ryniec headshot

5 Stocks on Sale: Values or Traps?

by Tracey Ryniec

Tracey discusses 5 stocks that have had big market sell-offs. Should they be on your watch list?

Zacks Equity Research

Abercrombie & Fitch and AMN Healthcare Services in the Box have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Abercrombie & Fitch and AMN Healthcare Services in the Box have been highlighted as Zacks Bull and Bear of the Day

Tracey Ryniec headshot

Bear of the Day: AMN Healthcare Services (AMN)

by Tracey Ryniec

Shares have tumbled to new 5-year lows.

Zacks Equity Research

Gap and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Gap and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day

Tracey Ryniec headshot

Bear of the Day: AMN Healthcare Services (AMN)

by Tracey Ryniec

There's no bottom yet in medical staffing.